Cryo-Cell Intl Inc (CCEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
| 08-2024 | 05-2024 | 02-2024 | 11-2023 | 08-2023 | |
| Sales | 8,067 | 8,043 | 7,852 | 7,877 | 7,870 |
| Cost of Goods | 2,126 | 2,025 | 2,066 | 2,024 | 2,156 |
| Gross Profit | 5,941 | 6,018 | 5,786 | 5,853 | 5,714 |
| Operating Expenses | 4,677 | 4,651 | 5,031 | 22,053 | 4,709 |
| Operating Income | 1,390 | 1,392 | 821 | -16,176 | 1,161 |
| Interest Expense | 534 | 329 | 257 | -169 | 470 |
| Other Income | 524 | 410 | 230 | 14 | 376 |
| Pre-tax Income | 1,380 | 1,472 | 795 | -15,993 | 1,068 |
| Income Tax | 328 | 816 | 238 | -4,803 | 387 |
| Net Income Continuous | 1,052 | 656 | 556 | -11,190 | 681 |
| Net Income | $1,052 | $656 | $556 | $-11,190 | $681 |
| EPS Basic Total Ops | 0.13 | 0.08 | 0.07 | -1.34 | 0.08 |
| EPS Basic Continuous Ops | 0.13 | 0.08 | 0.07 | -1.34 | 0.08 |
| EPS Diluted Total Ops | 0.13 | 0.08 | 0.07 | -1.34 | 0.08 |
| EPS Diluted Continuous Ops | 0.13 | 0.08 | 0.07 | -1.34 | 0.08 |
| EPS Diluted Before Non-Recurring Items | 0.13 | 0.08 | 0.07 | 0.26 | N/A |
| EBITDA(a) | $1,728 | $1,585 | $988 | $-15,761 | $1,586 |